These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 29394602)
41. [Complete Response in a Patient with HER2-Positive Gastric Cancer and Multiple Lung Metastases with Trastuzumab-Containing Chemotherapy]. Nakata W; Tokuyama N; Yagioka H; Suyama Y; Ogura K Gan To Kagaku Ryoho; 2016 May; 43(5):625-7. PubMed ID: 27210096 [TBL] [Abstract][Full Text] [Related]
42. [A Case of HER2-Positive Advanced Gastric Cancer with a Pathological Complete Response to Neoadjuvant Chemotherapy with S-1/CDDP/Trastuzumab]. Nishino M; Hosoda Y; Okano M; Nagai K; Yasui M; Kim Y; Tsujinaka T Gan To Kagaku Ryoho; 2015 Nov; 42(12):2043-5. PubMed ID: 26805258 [TBL] [Abstract][Full Text] [Related]
43. Preoperative chemotherapy with a trastuzumab-containing regimen for a patient with gastric cancer and hepatic metastases. Li ZY; Shan F; Zhang LH; Bu ZD; Wu AW; Wu XJ; Zong XL; Li SX; Ji X; Ji JF Genet Mol Res; 2014 Dec; 13(4):10952-7. PubMed ID: 25526216 [TBL] [Abstract][Full Text] [Related]
44. [A Case of Advanced Gastric Cancer with Liver Metastasis Treated by Curative Surgery after Chemotherapy Using S-1 plus Oxaliplatin]. Namikawa T; Kawanishi Y; Fujieda Y; Fujisawa K; Munekage E; Munekage M; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K Gan To Kagaku Ryoho; 2017 Nov; 44(12):1446-1448. PubMed ID: 29394663 [TBL] [Abstract][Full Text] [Related]
45. [A case of advanced gastric cancer in which the serum HER2-ECD level could be used as a biomarker]. Terakawa H; Oyama K; Watanabe T; Tsukada T; Okamoto K; Kinoshita J; Furukawa H; Makino I; Nakamura K; Hayashi H; Inokuchi M; Nakagawara H; Miyashita T; Tajima H; Takamura H; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Ohta T Gan To Kagaku Ryoho; 2014 Apr; 41(4):491-3. PubMed ID: 24743367 [TBL] [Abstract][Full Text] [Related]
46. Clinical outcomes of radical gastrectomy following trastuzumab-based chemotherapy for stage IV HER2-positive gastric or gastroesophageal junction cancer. Takahashi R; Nunobe S; Osumi H; Takahari D; Yamamoto N; Ida S; Kumagai K; Ohashi M; Sano T; Hiki N Surg Today; 2020 Oct; 50(10):1240-1248. PubMed ID: 32451714 [TBL] [Abstract][Full Text] [Related]
47. [A case of 10-year survival after combination chemotherapy of 5'-deoxy-5-fluorouridine and cisplatin and adjuvant surgery for gastric cancer with liver metastasis]. Ichikawa J; Koizumi W; Tanabe S; Takeuchi H; Nagaba S; Higuchi K; Sasaki T; Tahara K; Murakami S; Kitamura T; Nakai H; Saigenji K Gan To Kagaku Ryoho; 2004 Feb; 31(2):255-8. PubMed ID: 14997763 [TBL] [Abstract][Full Text] [Related]
48. [Two cases of unresectable advanced HER2-positive gastric cancer perforation during chemotherapy with trastuzumab]. Matsueda K; Toyokawa T; Ueda Y; Endo S; Sakata M; Fujita I; Horii J; Murakami T Nihon Shokakibyo Gakkai Zasshi; 2017; 114(1):59-68. PubMed ID: 28070095 [TBL] [Abstract][Full Text] [Related]
49. [A Case of Advanced Gastric Cancer with Extensive Lymph Node Metastasis That Showed pCR to Preoperative Chemotherapy ContainingXP]. Nanishi K; Kosuga T; Kubota T; Okamoto K; Konishi H; Shiozaki A; Fujiwara H; Shoda K; Arita T; Morimura R; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Otsuji E Gan To Kagaku Ryoho; 2018 Dec; 45(13):2345-2347. PubMed ID: 30692459 [TBL] [Abstract][Full Text] [Related]
50. Is there any advantage to combined trastuzumab and chemotherapy in perioperative setting her 2neu positive localized gastric adenocarcinoma? Sbitti Y; Essaidi I; Debbagh A; Kadiri H; Oukabli M; Moussaid Y; Slimani K; Fetohi M; Elkaoui H; Albouzidi A; Mahi M; Ali AA; Ichou M; Errihani H World J Surg Oncol; 2011 Sep; 9():112. PubMed ID: 21955806 [TBL] [Abstract][Full Text] [Related]
51. [A Case of Advanced Gastric Cancer with Synchronous Liver Metastases Treated with Combination Therapy]. Ebisui C; Okada K; Nushijima Y; Yanagisawa T; Okamura S; Fukuchi N; Murata K; Yokouchi H; Ohishi K; Tamai M; Kinuta M Gan To Kagaku Ryoho; 2015 Nov; 42(12):1989-91. PubMed ID: 26805240 [TBL] [Abstract][Full Text] [Related]
52. [A Case of HER2-Positive Esophagogastric Junction Cancer with Perforation Curatively Resected after Neoadjuvant Chemotherapy plus Trastuzumab]. Toshima H; Hisamatsu A; Shimada K; Saito M; Suzuki M; Matsukawa M; Inoue H Gan To Kagaku Ryoho; 2016 Jun; 43(6):761-4. PubMed ID: 27306816 [TBL] [Abstract][Full Text] [Related]
53. [A Long-Term Survival Case of HER2-Positive Gastric Cancer with Distant Lymph Node Metastasis Receiving Multidisciplinary Therapy]. Yasuoka S; Urakawa S; Kato J; Kidogami S; Fukata T; Nishida H; Ohigashi H; Takemoto H; Fukuzaki T Gan To Kagaku Ryoho; 2023 Dec; 50(13):1816-1818. PubMed ID: 38303217 [TBL] [Abstract][Full Text] [Related]
54. [Two cases of human epidermal growth factor receptor 2-positive advanced gastric cancer successfully treated with S-1, cisplatin, and trastuzumab combination therapy followed by curative resection]. Yasuyama A; Mikata S; Soma Y; Yoshikawa Y; Watase C; Kubota M; Miyake Y; Matsuura Y; Kim HM; Murakami M; Hirota M; Morishima H; Matsunami N; Hasegawa J; Miwa H; Nezu R Gan To Kagaku Ryoho; 2013 Nov; 40(12):2203-6. PubMed ID: 24394060 [TBL] [Abstract][Full Text] [Related]
55. The effectiveness of trastuzumab (Herceptin) combined with chemotherapy for gastric carcinoma with overexpression of the c-erbB-2 protein. Rebischung C; Barnoud R; Stéfani L; Faucheron JL; Mousseau M Gastric Cancer; 2005; 8(4):249-52. PubMed ID: 16328600 [TBL] [Abstract][Full Text] [Related]
56. [Two cases of stage IV gastric cancer treated by resection of the primary tumor after chemotherapy combined with trastuzumab]. Nakayama Y; Kawasaki H; Wajima N; Kimura A; Nakai M; Yonaiyama S; Hakamada K Gan To Kagaku Ryoho; 2013 Nov; 40(12):2188-90. PubMed ID: 24394055 [TBL] [Abstract][Full Text] [Related]
57. [A case report of neuroendocrine carcinoma of the stomach with liver metastases curatively resected after neoadjuvant chemotherapy]. Hokonohara K; Takata A; Noda T; Imamura H; Hirota M; Oshima K; Tanida T; Hatano H; Komori T; Morita S; Iwazawa T; Akagi K; Adachi S; Dono K Gan To Kagaku Ryoho; 2014 Nov; 41(12):2287-9. PubMed ID: 25731498 [TBL] [Abstract][Full Text] [Related]
58. [A case of advanced gastric cancer which became operable after chemotherapy with combination of TS-1/CDDP and in which complete disappearance of liver metastasis was histopathologically confirmed]. Meguro E; Kaizuka H; Inaba T; Irinoda T; Hayakawa Y; Okada S; Yamaguchi S; Wakabayashi J Gan To Kagaku Ryoho; 2003 Jun; 30(6):863-7. PubMed ID: 12852358 [TBL] [Abstract][Full Text] [Related]
59. Successful use of Trastuzumab with anthracycline-based chemotherapy followed by trastuzumab maintenance in patients with advanced HER2-positive gastric cancer. Palacio S; Loaiza-Bonilla A; Kittaneh M; Kyriakopoulos C; Ochoa RE; Escobar M; Arango B; Restrepo MH; Merchan JR; Rocha Lima CM; Hosein PJ Anticancer Res; 2014 Jan; 34(1):301-6. PubMed ID: 24403478 [TBL] [Abstract][Full Text] [Related]
60. [A case of advanced gastric cancer successfully treated with trastuzumab, capecitabine, and Cisplatin therapy followed by curative resection]. Kato S; Asao Y; Aisu Y; Honda K; Ando Y; Nishino H; Nishiuchi A; Kadokawa Y; Machimoto T; Furuyama H; Yoshimura T Gan To Kagaku Ryoho; 2014 Nov; 41(12):2311-3. PubMed ID: 25731506 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]